Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 3:8:640.
doi: 10.1186/s13104-015-1645-3.

Coffee consumption and NAFLD: a community based study on 1223 subjects

Collaborators, Affiliations

Coffee consumption and NAFLD: a community based study on 1223 subjects

Tilmann Graeter et al. BMC Res Notes. .

Abstract

Background: Objective of the present cross-sectional study was to investigate the impact of caffeine consumption on fatty liver and serum alanine aminotransferase (ALT) concentrations in a random population sample.

Methods: All subjects (n = 1452; 789 women, 663 men; average age 42.3 ± 12.8 years) underwent ultrasonographic examination of the liver and completed a standardized questionnaire regarding personal and lifestyle data, in particular relating to coffee consumption and past medical history. In addition, anthropometric data were documented and laboratory examinations performed. Statistical interpretation of the data was performed descriptively and by means of bivariate and multivariate analysis.

Results: Data of the present study demonstrated a significant association between hepatic steatosis male gender (p < 0.0001), advanced age (p < 0.0001) and elevated body-mass index (BMI; p < 0.0001). No association between caffeine consumption and fatty liver was identified. An association between caffeine consumption and elevated serum ALT concentrations was not identified.

Conclusions: The findings of the present study provide no evidence for an association between caffeine consumption and either the prevalence of hepatic steatosis or serum ALT concentrations.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow of the subject across the study
Fig. 2
Fig. 2
Caffeine consumption in relation to the severity of hepatic steatosis

Similar articles

Cited by

References

    1. Sanyal AJ. NASH: a global health problem. Hepatol Res. 2011;41:670–674. doi: 10.1111/j.1872-034X.2011.00824.x. - DOI - PubMed
    1. Ballestri S, Lonardo A, Bonapace S, et al. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20:1724–1745. doi: 10.3748/wjg.v20.i7.1724. - DOI - PMC - PubMed
    1. Takaki A, Kawai D, Yamamoto K. Molecular mechanisms and new treatment strategies for Non-Alcoholic Steatohepatitis (NASH) Int J Mol Sci. 2014;15:7352–7379. doi: 10.3390/ijms15057352. - DOI - PMC - PubMed
    1. Qayyum A, Chen DM, Breiman RS, Westphalen AC, Yeh BM, Jones KD, Lu Y, Coakley FV, Callen PW. Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? Clin Imaging. 2009;33:110–115. doi: 10.1016/j.clinimag.2008.06.036. - DOI - PMC - PubMed
    1. Torres DM, Williams CD, Harrison SA. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2012;10:837–858. doi: 10.1016/j.cgh.2012.03.011. - DOI - PubMed

Publication types

MeSH terms